X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/iaso-bio-presented-clinical-data-and-single-cell-analysis-of-equecabtagene-autoleucel-for-the-treatment-of-central-nervous-system-autoimmunity-in-oral-presentation-at-ean-congress-2024-302186742.html
https://www.prnewswire.com/news-releases/comprehensively-covering-multiple-myeloma-iaso-bios-gprc5d-car-t-product-rd118-receives-ind-approval-from-nmpa-302185666.html
https://www.prnewswire.com/news-releases/iaso-bio-presented-new-data-of-fucaso-equecabtagene-autoleucel-for-the-treatment-of-high-risk-newly-diagnosed-multiple-myeloma-in-oral-presentation-at-eha-2024-302173593.html
https://www.prnewswire.com/news-releases/single-cell-multi-omics-analysis-of-iaso-bios-equecabtagene-autoleucel-in-the-treatment-of-autoimmune-diseases-of-the-central-nervous-system-published-in-science-immunology-302142855.html
https://www.prnewswire.com/news-releases/iaso-bio-announces-us-fda-approval-of-investigational-new-drug-application-for-bcma-car-t-equecabtagene-autoleucel-for-generalized-myasthenia-gravis-302107854.html
https://www.prnewswire.com/news-releases/iaso-bio-announces-nmpas-ind-approval-for-equecabtagene-autoleucel-in-second--and-third-line-treatment-of-multiple-myeloma-302103455.html
https://www.prnewswire.com/news-releases/iaso-bio-announces-new-development-partnership-with-umoja-biopharma-to-develop-ex-vivo-and-in-vivo-cell-and-gene-therapies-302025270.html
https://www.prnewswire.com/news-releases/iaso-bio-and-innovent-present-new-data-of-fucaso-equecabtagene-autoleucel-for-multiple-myeloma-patients-in-oral-presentation-at-ash-2023-302011244.html
Market Place
Share 
